| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/22/2009 | CN101411763A Medicament for treating highly pathogenic blue ear disease and preparation method thereof |
| 04/22/2009 | CN100480269C Anti-vegf antibodies |
| 04/22/2009 | CN100480232C L-(-)-moprolol l-(+)-tartrate |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479826C Ribavirin eye gel eye medicine and producing process thereof |
| 04/22/2009 | CN100479818C A pharmaceutical formulation in the treatment of inner ear diseases and application method thereof |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2225761C Difluoroprostaglandin derivatives and their use |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009047640A2 Method for treating and/or preventing photoreceptor damage in retina |
| 04/16/2009 | WO2007136759A3 Method for the treatment and prevention of ocular disorders |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099373 Compositions enriched in anthocyanins |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099230 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/16/2009 | US20090099181 Sulfoximines as kinase inhibitors |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099114 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099100 Compositions and methods for treating amyloidosis |
| 04/16/2009 | US20090098136 Use of tnf receptor antagonists for treating dry eye |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | US20090098093 Generation of inner ear cells |
| 04/16/2009 | CA2701793A1 Monoclonal antibody |
| 04/16/2009 | CA2701482A1 Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2046714A2 Therapeutic compounds |
| 04/15/2009 | EP2046451A1 Monoamine oxidase inhibitors useful for treating disorders of the outer retina |
| 04/15/2009 | EP2046382A2 scFv ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS |
| 04/15/2009 | EP2046349A1 Treatment of excessive neovascularization |
| 04/15/2009 | EP2046287A2 Methods and compositions for the treatment and prevention of infections |
| 04/15/2009 | EP1519731B1 Combination of azelastine and fluticasone |
| 04/15/2009 | EP1480678B1 Treatment of ophthalmic disorders using urea and urea derivatives |
| 04/15/2009 | EP1423115B1 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1297849B1 Remedial agent for optic nerve diseases |
| 04/15/2009 | EP1267882B1 Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1003474B1 Method of treating dry eye disease with purinergic receptor agonists |
| 04/15/2009 | CN101410104A Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| 04/15/2009 | CN101406596A Medicament for treating dry eye |
| 04/15/2009 | CN101406570A Medicinal liquor for treating pearl eye and preparation method |
| 04/15/2009 | CN101406483A Method for producing liquor for treating eye symptoms |
| 04/15/2009 | CN101406480A Use of hyaluronic acid in preparing oral product for preventing and treating myopia |
| 04/15/2009 | CN100478025C Cyclosporia A microemulsion for eye and its preparation method |
| 04/15/2009 | CN100477990C Tanshinoue dropping pills and preparing method |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517907 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/14/2009 | CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2355341C The use of ara as a supplement for a lactating woman |
| 04/09/2009 | WO2009045172A1 Method and/or kit for determining response to muscarinic receptor antagonist treatment |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044423A1 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 04/09/2009 | WO2009044294A2 Means and methods for the treatment of cataract and presbyopia |
| 04/09/2009 | WO2009043116A1 Methods and compositions for the treatment of phosphatase- related disorders |
| 04/09/2009 | WO2009043106A1 Inorganic selenium and angiogenesis |
| 04/09/2009 | WO2009043093A1 Hif inhibition |
| 04/09/2009 | WO2009005551A3 Transcription factor modulating compounds and methods of use thereof |
| 04/09/2009 | US20090093780 Intraocular iontophoretic device and associated methods |
| 04/09/2009 | US20090093613 Treatment of tinnitus |
| 04/09/2009 | US20090093539 Anti-angiogenic compositions and methods of use thereof |
| 04/09/2009 | US20090093516 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | US20090093489 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 04/09/2009 | US20090093421 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| 04/09/2009 | US20090093409 Neuroprotective synergy of erythropoietin and insulin-like growth factors |
| 04/09/2009 | US20090092665 OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR mTOR INHIBITORS |
| 04/09/2009 | US20090092654 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System |
| 04/09/2009 | US20090092574 Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| 04/09/2009 | CA2701721A1 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 04/09/2009 | CA2701470A1 Sustained delivery of compstatin analogs from gels |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701116A1 Alkoxy compounds for disease treatment |
| 04/08/2009 | EP2045241A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2044951A1 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 04/08/2009 | EP2044145A1 Porous polymeric articles |
| 04/08/2009 | EP2044061A2 Benzothiophene inhibitors of rho kinase |
| 04/08/2009 | EP2043656A2 New medical use of triazine derivatives |
| 04/08/2009 | EP2043628A2 Ultraviolet absorbing ophthalmic compositions |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1179345B1 Inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 04/08/2009 | EP1059925B1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 04/08/2009 | CN101405009A Ophthalmic composition comprising xanthan gum and glucose |
| 04/08/2009 | CN101401791A Timolol liposome and preparation method thereof |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475190C Implantation slow release medicine in eyes |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |